$5.75
-0.28-4.64%
At close: -
$5.47
-0.28-4.87%
After Hours: 4:10 PM EDT
Comments
Loading...
Corvus Pharma (CRVS) Forecast
NewsEarningsCorvus Pharma (CRVS) OptionsGuidanceDividendsAnalyst RatingsInsider TradesShort InterestCorvus Pharma (NASDAQ:CRVS) Stock Quotes, Forecast and News Summary
Corvus Pharma Stock (NASDAQ: CRVS) stock price, news, charts, stock research, profile.
Compare
EPS worse than industry
Earnings Per Share
EPS is the portion of a company's profit allocated to each outstanding share of common stock. It is a key metric for investors to assess a company's profitability.
Earnings Per Share
EPS is the portion of a company's profit allocated to each outstanding share of common stock. It is a key metric for investors to assess a company's profitability.
EPS worse than industry
FAQ
How do I buy Corvus Pharma (CRVS) stock?
You can purchase shares of Corvus Pharma (NASDAQ:CRVS) through any online brokerage.
Who are Corvus Pharma (CRVS) competitors?
Other companies in Corvus Pharma’s space includes: KalVista Pharma (NASDAQ:KALV), Valneva (NASDAQ:VALN), Precigen (NASDAQ:PGEN), Korro Bio (NASDAQ:KRRO) and Sage Therapeutics (NASDAQ:SAGE).
What is the forecast, or price target, for Corvus Pharma (CRVS) stock?
Corvus Pharma has a consensus price target of $10.60.
What is the current price for Corvus Pharma (CRVS)?
The stock price for Corvus Pharma (NASDAQ: CRVS) is $5.47 last updated January 7, 2025 at 4:10 PM EST.
Does Corvus Pharma (CRVS) pay a dividend?
There are no upcoming dividends for Corvus Pharma.
When is Corvus Pharma (NASDAQ:CRVS) reporting earnings?
Corvus Pharma’s Q4 earnings are confirmed for Tuesday, March 18, 2025.
Is Corvus Pharma (CRVS) going to split?
There is no upcoming split for Corvus Pharma.
What sector and industry does Corvus Pharma (CRVS) operate in?
Corvus Pharma is in the Health Care sector and Biotechnology industry. They are listed on the NASDAQ.